RENB has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RENB has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2025-04-22), Renovaro's 12-1 Month Momentum % is -67.72%.
The industry rank for Renovaro's 12-1 Month Momentum % or its related term are showing as below:
For the Biotechnology subindustry, Renovaro's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Renovaro's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Renovaro's 12-1 Month Momentum % falls into.
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum % | = | ( Price 1-month ago | / | Price 12-month ago | - 1 ) | * | 100 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Renovaro (NAS:RENB) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Thank you for viewing the detailed overview of Renovaro's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Anderson Wittekind William | 10 percent owner | 8581 SANTA MONICA BLVD, LOS ANGELES CA 90069 |
Leni Boeren | director | 2080 CENTURY PARK EAST, #906, LOS ANGELES CA 90067 |
Ruud Hendriks | director | CHATEAU D'AZUR, BLVD D'LTALIE 44, MONACO O9 C11298000 |
Ole Abildgaard | 10 percent owner | VEDBAEK STRANDVEJ 506, VEDBAEK G7 2950 |
Francois Binette | officer: Executive Vice President | 2022 N. ALVARADO STREET, LOS ANGELES CA 90039 |
Serhat Gumrukcu | 10 percent owner | 2080 CENTURY CITY EAST, SUITE 906, LOS ANGELES CA 90067 |
Rene Sindlev | director, 10 percent owner | FRUEBJERGVEJ 3 BOX 62, COPENHAGEN G7 2100 |
Carl Forest Sandler | other: Former director see note below | 330 EAST 33RD STREET, APARTMENT 3A, NEW YORK FL 10016 |
Jayne Mcnicol | director | 606 NORTHERN AVENUE, MILL VALLEY CA 94941 |
Gregg H Alton | director | 333 LAKESIDE DRIVE, FOSTER CITY CA 94404 |
Carol L Brosgart | director | C/O TOBIRA THERAPEUTICS, INC., 701 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO CA 94080 |
Henrik Gronfeldt-sorensen | director | STUMPEDYSSEVEJ 17, HORSHOLM G7 2970 |
Luisa Puche | officer: Chief Financial Officer | 318 NE 104TH STREET, MIAMI FL 33138 |
Luc Debruyne | director | NOORDENWINDHELLING 2 02/05, OOSTDUINKERKE C9 8670 |
Leire, Eric Jean Marie | director, officer: CEO; President | C/O DANDRIT BIOTECH USA, INC., P.O. BOX 189, RANDOLPH VT 05060 |
From GuruFocus
By GuruFocus News • 04-04-2025
By Marketwired • 04-24-2024
By Marketwired • 02-26-2025
By Marketwired • 12-20-2024
By Marketwired • 06-14-2024
By Marketwired • 03-03-2025
By Marketwired • 01-07-2025
By Marketwired • 09-19-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.